GAD treatment and insulin secretion in recent-onset type 1 diabetes

Cited by (520)

Items 101–200 of 520

1. Treatment of Type 1 Diabetic Patients with Glucagon-Like Peptide-1 (GLP-1) and GLP-1R Agonists
   Urd Lynge Kielgast, Jens Juul Holst, Sten Madsbad · 2009 · Current Diabetes Reviews
2. Non‐food/feed seeds as biofactories for the high‐yield production of recombinant pharmaceuticals
   Francesca Morandini, Linda Avesani, Luisa Bortesi, Bart Van Droogenbroeck, Kirsten De Wilde, Elsa Arcalís, Flavia Bazzoni, Luca Santi, Annalisa Brozzetti, Alberto Falorni et al. · 2011 · Plant Biotechnology Journal
3. GAD vaccine reduces insulin loss in recently diagnosed type 1 diabetes: findings from a Bayesian meta-analysis
   the Type 1 Diabetes TrialNet Study Group, Beam, Craig A., MacCallum, Colleen, Herold, Kevan C., Wherrett, Diane K., Palmer, Jerry, Ludvigsson, Johnny · 2017 · Diabetologia
4. Concise Review: Apoptotic Cell-Based Therapies–Rationale, Preclinical Results and Future Clinical Developments
   Philippe Saas, Étienne Daguindau, Sylvain Perruche · 2016 · Stem Cells
5. β-Cell Protection and Therapy for Latent Autoimmune Diabetes in Adults
   Simona Cernea, Raffaella Buzzetti, Paolo Pozzilli · 2009 · Diabetes Care
6. Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial
   Ludvigsson, Johnny, Sumnik, Zdenek, Pelikanova, Terezie, Nattero Chavez, Lia, Lundberg, Elena, Rica, Itxaso, Martínez-Brocca, Maria A., Ruiz de Adana, Marisol, Wahlberg, Jeanette, Katsarou, Anastasia et al. · 2021 · Diabetes Care
7. The Increasing Onset of Type 1 Diabetes in Children
   Kevin Hummel, Kim McFann, Jaime Realsen, Laurel H. Messer, GEORGEANNA JONES KLINGENSMITH, H. Peter Chase · 2012 · The Journal of Pediatrics
8. Targeting Regulatory T Cells in the Treatment of Type 1 Diabetes Mellitus
   Susanne M. Cabrera, Mark R. Rigby, Raghavendra G. Mirmira · 2012 · Current Molecular Medicine
9. Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapy
   Chiara Guglielmi, Andrea Palermo, Paolo Pozzilli · 2012 · Diabetes/Metabolism Research and Reviews
10. Residual beta cell function at diagnosis of type 1 diabetes in children and adolescents varies with gender and season
    Ulf Samuelsson, Bengt Lindblad, Annelie Carlsson, Gun Forsander, Sten Anders Ivarsson, Ingrid Skelton Kockum, Åke Lernmark, Claude Marcus, Johnny Ludvigsson, Better Diabetes Diagnosis (BDD) study group · 2012 · Diabetes/Metabolism Research and Reviews
11. T‐cell autoantigens in the non‐obese diabetic mouse model of autoimmune diabetes
    Jeffrey Babad, Ari Geliebter, Teresa P. DiLorenzo · 2010 · Immunology
12. Immune intervention with T regulatory cells: Past lessons and future perspectives for type 1 diabetes
    Manuela Battaglia, Maria‐Grazia Roncarolo · 2011 · Seminars in Immunology
13. GAD-65 autoantibodies and their role as biomarkers of type 1 diabetes and latent autoimmune diabetes in adults (LADA)
    R. Towns, M. Pietropaolo · 2011 · Drugs of the Future
14. Therapy with GAD in diabetes
    Johnny Ludvigsson · 2009 · Diabetes/Metabolism Research and Reviews
15. Immune intervention in type 1 diabetes
    Michels, Aaron W., Eisenbarth, George S. · 2011 · Seminars in Immunology
16. A randomized trial of oral gamma aminobutyric acid (GABA) or the combination of GABA with glutamic acid decarboxylase (GAD) on pancreatic islet endocrine function in children with newly diagnosed type 1 diabetes
    Alexandra Martin, Gail J. Mick, Heather M. Choat, Alison Lunsford, Hubert Ming Tse, Gerald G. McGwin, Kenneth L. McCormick · 2022 · Nature Communications
17. Alteration of Regulatory T Cells in Type 1 Diabetes Mellitus: A Comprehensive Review
    Tingting Tan, Yufei Xiang, Christopher C. Chang, Zhiguang Zhou · 2014 · Clinical Reviews in Allergy & Immunology
18. GAD Autoantibody Affinity in Adult Patients With Latent Autoimmune Diabetes, the Study Participants of a GAD65 Vaccination Trial
    Stephanie Krause, Ulrike Landherr, Carl‐David Agardh, Simone Hausmann, Katarina Link, Jesse M. Hansen, Kristian Francis Lynch, Michael Joseph Powell, Jadwiga Furmaniak, Bernard Rees-Smith et al. · 2014 · Diabetes Care
19. Combining Antigen-Based Therapy with GABA Treatment Synergistically Prolongs Survival of Transplanted ß-Cells in Diabetic NOD Mice
    Jide Tian, Hoa N. Dang, Daniel L. Kaufman · 2011 · PLoS ONE
20. Effect of Ingested Interferon-α on β-Cell Function in Children With New-Onset Type 1 Diabetes
    Kristina I. Rother, Rebecca J. Brown, Miriam M. Morales, Elizabeth C. Wright, Zhigang Duan, Carol Campbell, Dana Sue Hardin, Jadranka Popovic, Robert C. McEvoy, David M. Harlan et al. · 2009 · Diabetes Care
21. Predicting Adult-Onset Autoimmune Diabetes
    Leslie, R. David · 2010 · Diabetes
22. Pancreatic islet autoimmunity
    Christian Boîtard · 2012 · La Presse Médicale
23. Sample Size Requirements for Studies of Treatment Effects on Beta-Cell Function in Newly Diagnosed Type 1 Diabetes
    John M. Lachin, Paula L. McGee, Carla J. Greenbaum, Jerry P. Palmer, Mark D. Pescovitz, Peter A. Gottlieb, Jay S. Skyler, Type 1 Diabetes Trial Network · 2011 · PLoS ONE
24. Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 Diabetes
    Carla J. Greenbaum, Desmond Schatz, Michael J. Haller, Srinath Sanda · 2012 · Diabetes
25. Tolerogenic dendritic cells impede priming of naïve CD 8+ T cells and deplete memory CD 8+ T cells
    Fleur S. Kleijwegt, Diahann T. S. L. Jansen, Josefine Teeler, Antoinette M. Joosten, Sandra Laban, Tatjana Nikolić, Bart O. Roep · 2012 · European Journal of Immunology
26. Trials in type 1 diabetes: Antigen-specific therapies
    Ken T. Coppieters, Leonard C. Harrison, Matthias G. von Herrath · 2013 · Clinical Immunology
27. An Insulin‐Inspired Supramolecular Hydrogel for Prevention of Type 1 Diabetes
    Mohan Liu, Zhongyan Wang, Dandan Feng, Yuna Shang, Xinxin Li, Jianfeng Liu, Chen Li, Zhimou Yang · 2021 · Advanced Science
28. Antigen-Specific Therapeutic Approaches in Type 1 Diabetes
    Xavier Clemente‐Casares, Sue Jean Tsai, C. Huang, Pere Santamaría · 2011 · Cold Spring Harbor Perspectives in Medicine
29. GAD-treatment of children and adolescents with recent-onset type 1 diabetes preserves residual insulin secretion after 30 months
    Ludvigsson, Johnny, Chéramy, Mikael, Axelsson, Stina, Pihl, Mikael, Åkerman, Linda, Casas, Rosaura, for the clinical GAD‐study group in Sweden · 2014 · Diabetes/Metabolism Research and Reviews
30. Combination immunotherapy for type 1 diabetes
    Bone, Robert N., Evans-Molina, Carmella · 2017 · Current Diabetes Reports
31. The future of type 1 diabetes therapy
    Ziegler, Anette-Gabriele, Cengiz, Eda, Kay, Thomas W H · 2025 · The Lancet
32. Combination therapy for preservation of beta cell function in Type 1 diabetes: New attitudes and strategies are needed!
    Johnny Ludvigsson · 2014 · Immunology Letters
33. Immune Mechanisms and Pathways Targeted in Type 1 Diabetes
    Laura M. Jacobsen, Brittney N. Newby, Daniel J. Perry, Amanda L. Posgai, Michael J. Haller, Todd M. Brusko · 2018 · Current Diabetes Reports
34. New and future immunomodulatory therapy in type 1 diabetes
    James Tooley, Frank Waldron-Lynch, Kevan C. Herold · 2012 · Trends in Molecular Medicine
35. Long-Lasting Immune Responses 4 Years after GAD-Alum Treatment in Children with Type 1 Diabetes
    Stina Axelsson, Mikael Chéramy, Maria Hjorth, Mikael Pihl, Linda Åkerman, Emanuela Martinuzzi, Roberto Mallone, Johnny Ludvigsson, Rosaura Casas · 2011 · PLoS ONE
36. GAD-alum treatment in patients with type 1 diabetes and the subsequent effect on GADA IgG subclass distribution, GAD65 enzyme activity and humoral response
    Mikael Chéramy, Camilla Skoglund, Ingela Johansson, Johnny Ludvigsson, Christiane S. Hampe, Rosaura Casas · 2010 · Clinical Immunology
37. Content validity of the PedsQL™ 3.2 Diabetes Module in newly diagnosed patients with Type 1 diabetes mellitus ages 8–45
    James W. Varni, Bradley H. Curtis, Linda N. Abetz, Kathryn Lasch, Elisabeth Carine Piault, Andrea A. Zeytoonjian · 2012 · Quality of Life Research
38. Antigen-Based Vaccination and Prevention of Type 1 Diabetes
    Leonard C. Harrison, John M. Wentworth, Yuxia Zhang, Esther Bandala‐Sanchez, Ralph M. Böhmer, Alana M. Neale, Natalie L. Stone, Gaetano Naselli, Julian J. Bosco, Priscilla Auyeung et al. · 2013 · Current Diabetes Reports
39. Immunotherapy for the Prevention and Treatment of Type 1 Diabetes
    Damien Bresson, Matthias von Herrath · 2009 · Diabetes Care
40. Key Role of the GITR/GITRLigand Pathway in the Development of Murine Autoimmune Diabetes: A Potential Therapeutic Target
    Sylvaine You, Lynn D. Poulton, Stephen Paul Cobbold, Chih‐Pin Liu, Michael Rosenzweig, Douglas J. Ringler, Wen-Hui Lee, B Segovia, Jean‐François Bach, Herman Waldmann et al. · 2009 · PLoS ONE
41. What causes type 1 diabetes? Lessons from animal models
    Karsten Buschard · 2011 · Apmis
42. Exercise to preserve beta cell function in recent-onset type 1 diabetes mellitus (EXTOD) - a study protocol for a pilot randomized controlled trial
    Nadia Lascar, Amy Kennedy, Nikki Jackson, Amanda Daley, George Dowswell, Dylan Thompson, Keith Stokes, Sheila Greenfield, ROGER L. HOLDER, Robert Charles Andrews et al. · 2013 · Trials
43. Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment
    Damien Bresson, Georgia Fousteri, Yulia Manenkova, Michael Croft, Matthias von Herrath · 2011 · Journal of Autoimmunity
44. Genetic-induced Variations in the GAD65 T-cell Repertoire Governs Efficacy of Anti-CD3/GAD65 Combination Therapy in New-onset Type 1 Diabetes
    Damien Bresson, Matthew Fradkin, Yulia Manenkova, Diane Rottembourg, Matthias von Herrath · 2009 · Molecular Therapy
45. Antigen-based immunotherapy for autoimmune disease: current status
    Punita Ponda, Darren Hirsch · 2014 · ImmunoTargets and Therapy
46. Autoantigen Treatment in Type 1 Diabetes: Unsolved Questions on How to Select Autoantigen and Administration Route
    Johnny Ludvigsson · 2020 · International Journal of Molecular Sciences
47. Type 1 Diabetes: A Guide to Autoimmune Mechanisms for Clinicians
    François‐Xavier Mauvais, Peter Van Endert · 2025 · Diabetes Obesity and Metabolism
48. Teplizumab therapy for type 1 diabetes
    Umesh B. Masharani, Joseph U. Becker · 2010 · Expert Opinion on Biological Therapy
49. Prevention of Type 1 Diabetes
    Diane K. Wherrett, Denis Daneman · 2009 · Endocrinology and Metabolism Clinics of North America
50. Overcoming barriers in clinical islet transplantation: Current limitations and future prospects
    Preeti Chhabra, David E.R. Sutherland, Kenneth L. Brayman · 2013 · Current Problems in Surgery
51. The Yin and Yang of regulatory T cell and therapy progress in autoimmune disease
    Yong-chao Qiao, Yan-Hong Pan, Lin Wei, Fang Tian, Yin-ling Chen, Xiaoxi Zhang, Hai‐Lu Zhao · 2017 · Autoimmunity Reviews
52. Antigen-Based Therapy for the Treatment of Type 1 Diabetes
    Jide Tian, Daniel L. Kaufman · 2009 · Diabetes
53. Biomarkers for immune intervention trials in type 1 diabetes
    Roberto Mallone, Bart O. Roep · 2013 · Clinical Immunology
54. 2011 Update
    Aaron W. Michels, Matthias von Herrath · 2011 · Current Opinion in Endocrinology Diabetes and Obesity
55. Cellular and Humoral Immune Responses in Type 1 Diabetic Patients Participating in a Phase III GAD-alum Intervention Trial
    Stina Axelsson, Mikael Chéramy, Linda Åkerman, Mikael Pihl, Johnny Ludvigsson, Rosaura Casas · 2013 · Diabetes Care
56. Antigen-Based Immune Therapeutics for Type 1 Diabetes: Magic Bullets or Ordinary Blanks?
    Slobodan Čulina, Christian Boîtard, Roberto Mallone · 2011 · Clinical and Developmental Immunology
57. The clinical and immunological significance of GAD-specific autoantibody and T-cell responses in type 1 diabetes
    Tobias Boettler, Philippe P. Pagni, Rachel Jaffe, Yang Cheng, Peter Zerhouni, Matthias von Herrath · 2013 · Journal of Autoimmunity
58. Impact of Disease Heterogeneity on Treatment Efficacy of Immunotherapy in Type 1 Diabetes: Different Shades of Gray
    Nicky J. C. Woittiez, Bart O. Roep · 2015 · Immunotherapy
59. Approaches in type 1 diabetes research: A status report
    VR Rao, Oindrila Raha, Subhankar Chowdhury, Samir Dasgupta, P Raychaudhuri, BN Sarkar, PVeer Raju · 2009 · International Journal of Diabetes in Developing Countries
60. Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
    Jinsha Liu, Joey Paolo Ting, Shams Al-Azzam, Yun Ding, Sepideh Afshar · 2021 · International Journal of Molecular Sciences
61. Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials
    Carlos Eduardo Barra Couri, Júlio César Voltarelli · 2009 · Diabetology & Metabolic Syndrome
62. A historical view from thirty eventful years of immunotherapy in autoimmune diabetes
    Bach, Jean-François, Chatenoud, Lucienne · 2011 · Seminars in Immunology
63. Immunomodulation with heat shock protein DiaPep277 to preserve beta cell function in type 1 diabetes – an update
    Britta Fischer, Dana Elias, Reinhard G. Bretzel, Thomas Linn · 2009 · Expert Opinion on Biological Therapy
64. Remodeling rodent models to mimic human type 1 diabetes
    Matthias von Herrath, Gerald T. Nepom · 2009 · European Journal of Immunology
65. The Emerging Jamboree of Transformative Therapies for Autoimmune Diseases
    José M. Carballido, Camille Regairaz, Céline Rauld, Layla Raad, Damien Picard, Michael E. Kammuller · 2020 · Frontiers in Immunology
66. Glutamic Acid Decarboxylase Injection Into Lymph Nodes: Beta Cell Function and Immune Responses in Recent Onset Type 1 Diabetes Patients
    Rosaura Casas, Fabrícia Dietrich, Hugo Barcenilla, Beatriz Tavira, Jeanette Wahlberg, Peter Achenbach, Johnny Ludvigsson · 2020 · Frontiers in Immunology
67. From Disease and Patient Heterogeneity to Precision Medicine in Type 1 Diabetes
    Nicoline H. M. den Hollander, Bart O. Roep · 2022 · Frontiers in Medicine
68. Treatment of autoimmune diabetes in NOD mice by Toll-like receptor 2 tolerance in conjunction with dipeptidyl peptidase 4 inhibition
    D.-H. Kim, J.-C. Lee, Myeongcheol Lee, K.-W. Kim, M.-S. Lee · 2012 · Diabetologia
69. Current State of Type 1 Diabetes Immunotherapy: Incremental Advances, Huge Leaps, or More of the Same?
    Brett E. Phillips, M. Trucco, N. Giannoukakis · 2011 · Clinical and Developmental Immunology
70. Early induction of GAD65‐reactive Th2 response in type 1 diabetic children treated with alum‐formulated GAD65
    Stina Axelsson, Maria Hjorth, Linda Åkerman, Johnny Ludvigsson, Rosaura Casas · 2010 · Diabetes/Metabolism Research and Reviews
71. Novel targeted therapies for autoimmunity
    E. William St. Clair · 2009 · Current Opinion in Immunology
72. The immunological basis for treatment of stiff person syndrome
    Trygve Holmøy, Christian Geis · 2010 · Journal of Neuroimmunology
73. Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant
    Anna U. Bielinska, Jessica J. O’Konek, Katarzyna W. Janczak, James R. Baker · 2016 · Vaccine
74. Partial Clinical Remission of Type 1 Diabetes Mellitus in Children: Clinical Applications and Challenges with its Definitions
    Benjamin Udoka Nwosu · 2019 · European Medical Journal
75. LNP-mRNA vaccine prevents type 1 diabetes in non-obese diabetes mice
    Jiayin Chen, Yiqi Hu, Yan Chen, Ziqi Zhou, Yiming Shen, Yan Wang, Zichuan Liu, Xianglong Li, Zhigui Su, Jie Wu · 2024 · Journal of Controlled Release
76. Autologous Hematopoietic Stem Cell Transplantation for Childhood Autoimmune Disease
    Francesca Milanetti, Mario Abinun, Júlio César Voltarelli, Richard K. Burt · 2010 · Pediatric Clinics of North America
77. Immunotherapy Strategies for the Prevention and Treatment of Distinct Stages of Type 1 Diabetes: An Overview
    Novella Rapini, Riccardo Schiaffini, Alessandra Fierabracci · 2020 · International Journal of Molecular Sciences
78. Pancreatic duodenal homeobox 1 protein is a novel β-cell-specific autoantigen for type I diabetes
    Shiwu Li, Vijay Koya, Yi Li, William Donelan, Peng Lin, Westley H. Reeves, Lijun Yang · 2009 · Laboratory Investigation
79. 1,25-dihydroxyvitamin D 3 down-modulates the production of proinflammatory cytokines and nitric oxide and enhances the phosphorylation of monocyte-expressed STAT6 at the recent-onset type 1 diabetes
    Lamia Ysmail-Dahlouk, Wafa Nouari, Mourad Aribi · 2016 · Immunology Letters
80. Switch from a dominant Th1‐associated immune profile during the pre‐diabetic phase in favour of a temporary increase of a Th3‐associated and inflammatory immune profile at the onset of type 1 diabetes
    Anna Ryden, Kateřina Štechová, Marianna Durilová, Maria Faresjö · 2009 · Diabetes/Metabolism Research and Reviews
81. Clinical Immunologic Interventions for the Treatment of Type 1 Diabetes
    Lucienne Chatenoud, Katharina Warncke, Anette‐Gabriele Ziegler · 2012 · Cold Spring Harbor Perspectives in Medicine
82. Mechanistic Basis of Immunotherapies for Type 1 Diabetes Mellitus
    Wen-Hao Chen, A. Xie, L. Chan · 2013 · Translational Research: The Journal of Laboratory and Clinical Medicine
83. Insulin Pump Therapy Started at the Time of Diagnosis: Effects on Glycemic Control and Pancreatic β-Cell Function in Type 1 Diabetes
    Kathryn M. Thrailkill, Cynthia S. Moreau, Christopher J. Swearingen, Mallik Rettiganti, Kathy Edwards, Alba E. Morales, Stephen F. Kemp, J. Paul Frindik, John L. Fowlkes · 2011 · Diabetes Technology & Therapeutics
84. Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes
    Beatriz Tavira, Hugo Barcenilla, Jeannette Wahlberg, Peter Achenbach, Johnny Ludvigsson, Rosaura Casas · 2018 · Journal of Diabetes Research
85. Immune Regulation in T1D and T2D: Prospective Role of Foxp3+ Treg Cells in Disease Pathogenesis and Treatment
    Mara Kornete, Edward S. Mason, Ciriaco A. Piccirillo · 2013 · Frontiers in Endocrinology
86. The Role of Immunomodulation Therapy in Autoimmune Diabetes
    Johnny Ludvigsson · 2009 · Journal of Diabetes Science and Technology
87. Inducing immune tolerance: a focus on Type 1 diabetes mellitus
    Dan Xu, Suchitra Prasad, Stephen D. Miller · 2013 · Diabetes Management
88. A Swedish approach to the prevention of type 1 diabetes
    Helena Elding Larsson · 2016 · Pediatric Diabetes
89. Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the <scp>NewLira</scp> study): A randomized, double‐blind, placebo‐controlled trial
    Dejgaard, Thomas F., Frandsen, Christian S., Kielgast, Urd, Størling, Joachim, Overgaard, Anne J., Svane, Maria S., Olsen, Markus Harboe, Thorsteinsson, Birger, Andersen, Henrik U., Krarup, Thure et al. · 2024 · Diabetes, Obesity and Metabolism
90. Heat shock protein bystander antigens for peptide immunotherapy in autoimmune disease
    Evelien Zonneveld‐Huijssoon, Salvatore Albani, Berent Jan Prakken, Femke van Wijk · 2012 · Clinical & Experimental Immunology
91. Tolerogenic Iron Oxide Nanoparticles in Type 1 Diabetes: Biodistribution and Pharmacokinetics Studies in Nonobese Diabetic Mice
    Chloe Dubreil, Odile Sainte‐Catherine, Yoann Lalatonne, Clément Journé, Phalla Ou, Peter Van Endert, Laurence Motte · 2018 · Small
92. Administration of metrnl delays the onset of diabetes in non-obese diabetic mice
    Zhina Yao, Peng Lin, Chuan Wang, Kexin Wang, Yu Sun · 2020 · Endocrine Journal
93. α 1‐Antitrypsin modifies general natural killer cell interactions with dendritic cells and specific interactions with islet β ‐cells in favour of protection from autoimmune diabetes
    Ofer Guttman, Rami Yossef, Gabriella S. Freixo-Lima, Peleg Rider, Angel Porgador, Eli C. Lewis · 2014 · Immunology
94. Vaccination with a co‐expression DNA plasmid containing GAD65 fragment gene and IL‐10 gene induces regulatory CD4+ T cells that prevent experimental autoimmune diabetes
    Xinyuan Liu, Song Zhang, Xia Li, Peilin Zheng, Fang Hu, Zhiguang Zhou · 2016 · Diabetes/Metabolism Research and Reviews
95. Combination therapy with saxagliptin and vitamin D for the preservation of β-cell function in adult-onset type 1 diabetes: a multi-center, randomized, controlled trial
    Yan, Xiang, Li, Xia, Liu, Bingwen, Huang, Jiaqi, Xiang, Yufei, Hu, Yuhang, Tang, Xiaohan, Zhang, Ziwei, Huang, Gan, Xie, Zhiguo et al. · 2023 · Signal Transduction and Targeted Therapy
96. A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetes
    Alyssa Ylescupidez, Henry T. Bahnson, Colin O’Rourke, Sandra M. Lord, Cate Speake, Carla J. Greenbaum · 2023 · Nature Communications
97. Immunotherapy of type 1 diabetes — How to rationally prioritize combination therapies in T1D
    Tobias Boettler, Matthias von Herrath · 2010 · International Immunopharmacology
98. Therapies to Preserve β-Cell Function in Type 1 Diabetes
    Johnny Ludvigsson · 2015 · Drugs
99. Adequate doses of autoantigen administered using the appropriate route may create tolerance and stop autoimmunity
    Johnny Ludvigsson · 2008 · Diabetologia
100. Thymic self-antigens for the design of a negative/tolerogenic self-vaccination against type 1 diabetes
     Vincent G. Geenen, Marie Mottet, Olivier Dardenne, Hamid Kermani, Henri Martens, Jean-Marie Francois, Moreno Galleni, Didier Hober, Souad Rahmouni, Michel P. Moutschen · 2010 · Current Opinion in Pharmacology